Literature DB >> 7020614

Inflammatory synovial tissue mononuclear cells release leucocyte migration inhibition factor in antigen- and mitogen-free cultures.

T Egeland, O J Mellbye, J A Pahle.   

Abstract

The presence of leucocyte migration inhibition factor (LIF) in supernatants from apparently antigen- and mitogen-free cultures of mononuclear cells (MNC) was studied. MNC were eluted from inflamed synovial tissue or isolated from blood. Untreated supernatants, supernatants in which any LIF had been inactivated, and culture medium were compared in their ability to affect the migration of homologous polymorphonuclear leucocytes. LIF was released by synovial tissue MNC from all of the 9 patients studied, consisting of 5 patients with rheumatoid arthritis, 2 with psoriatic arthropathy, and 2 with juvenile rheumatoid arthritis. Blood MNC of the patients and of 8 healthy blood donors did not release LIF. When synovial tissue MNC supernatants from 2 patients were examined, LIF activity increased as time of incubation was extended. In at least 2 synovial tissue MNC supernatants in which LIF had been inactivated a migration enhancement activity was revealed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7020614      PMCID: PMC1000734          DOI: 10.1136/ard.40.4.388

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  24 in total

Review 1.  The immunopathology of joint inflammation in rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

2.  Immunglobulin classes, subclasses and complexes of IgG rheumatoid factor in rheumatoid plasma cells.

Authors:  E Munthe; J B Natvig
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

3.  Separation of blood leucocytes, granulocytes and lymphocytes.

Authors:  A Boyum
Journal:  Tissue Antigens       Date:  1974

4.  Lymphokine activity in vivo in relation to circulating monocyte levels and delayed skin reactivity.

Authors:  T Yoshida; S Cohen
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

5.  Activity of migration inhibitory factor in the absence of antigen.

Authors:  T Yoshida; C A Janeway; W E Paul
Journal:  J Immunol       Date:  1972-08       Impact factor: 5.422

6.  Migration enhancement factor: a new lymphokine.

Authors:  R H Weisbart; R Bluestone; L S Goldberg; C M Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

7.  Migration inhibitory effect of cell-free supernatants from tuberculin-stimulated cultures of human mononuclear leukocytes demonstrated by two-step MIF agarose assay.

Authors:  J E Clausen
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

8.  In citro migration of peripheral human leucocytes in cellular hypersensitivity.

Authors:  M Soborg
Journal:  Acta Med Scand       Date:  1968 Jul-Aug

9.  In vitro synthesis of immunoglobulin by rheumatoid synovial membrane.

Authors:  J D Smiley; C Sachs; M Ziff
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

10.  Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).

Authors:  R E Rocklin
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

View more
  8 in total

Review 1.  Immunoregulatory T cell subsets and T cell activation in rheumatoid arthritis. A need for analysis on the clonal and molecular level.

Authors:  A Quayle; J Kjeldsen-Kragh; O Førre; K Waalen; M Sioud; C Kalvenes; J B Natvig
Journal:  Springer Semin Immunopathol       Date:  1989

2.  Immunoregulatory lymphokines in rheumatoid joints. II. Production by and responsiveness to interleukin-2 of eluted synovial tissue cells.

Authors:  J Hovdenes; T Egeland
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

Review 3.  Cytokine modulation of chondrocyte metabolism--in vivo and in vitro effects of piroxicam.

Authors:  J H Herman; A M Appel; R C Khosla; K S Kelch; E V Hess
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

4.  Evidence for altered immunoregulation in rheumatoid arthritis.

Authors:  J H Dobloug; O Førre; C Chattopadhyay; J B Natvig
Journal:  Springer Semin Immunopathol       Date:  1981

Review 5.  Cytokines and other mediators in rheumatoid arthritis.

Authors:  J M Dayer; S Demczuk
Journal:  Springer Semin Immunopathol       Date:  1984

6.  Analysis of lymphocyte subsets of bone marrow in patients with rheumatoid arthritis by two colour immunofluorescence and flow cytometry.

Authors:  M Doita; S Maeda; K Kawai; K Hirohata; T Sugiyama
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

7.  Eluted rheumatoid synovial tissue T cell subsets and HLA-DR bearing cells at different stages of fractionation.

Authors:  T Egeland; O Førre
Journal:  Clin Rheumatol       Date:  1983-03       Impact factor: 2.980

8.  Spontaneous production of fibroblast-activating factor(s) by synovial inflammatory cells. A potential mechanism for enhanced tissue destruction.

Authors:  S M Wahl; D G Malone; R L Wilder
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.